New South Wales Supreme Court Awards Mayne Pharma Group Over AU$13 Million in Legal Costs Following Cosette Pharmaceuticals Proceedings; Shares Up 6%

MT Newswires Live05-22 11:09

Mayne Pharma Group (ASX:MYX) is entitled to nearly AU$13.3 million in legal costs following court proceedings against Cosette Pharmaceuticals in the New South Wales Supreme Court last year, according to a Friday filing with the Australian bourse.

The company initiated proceedings against Cosette Pharmaceuticals in June 2025 in relation to Cosette's purported termination of the scheme implementation deed signed by the two parties in February 2025, the filing said.

The court ruled in favor of the company in October 2025 and made an adverse costs order against Cosette, per the filing.

Mayne Pharma Group shares rose 6% in midday trade on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment